Fulgent Genetics Inc (FLGT) USD0.0001

Sell:$19.58Buy:$24.80$0.01 (0.02%)

NASDAQ:0.50%
Market closed | Prices delayed by at least 15 minutes
Sell:$19.58
Buy:$24.80
Change:$0.01 (0.02%)
Market closed | Prices delayed by at least 15 minutes
Sell:$19.58
Buy:$24.80
Change:$0.01 (0.02%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
2 June 2025
Hanlin (Harry) GaoChief Level Officer
Sell
Tax related
754$20.29$15,299.26961,281
2 June 2025
Jian (James) XiePresident/COO
Sell
Tax related
1,135$20.29$23,030.06371,496
1 June 2025
Paul KimCFO
Sell
Tax related
1,131$20.72$23,434.32342,571
27 May 2025
Hanlin (Harry) GaoChief Level Officer
Sell
Tax related
383$20.58$7,880.34962,691
27 May 2025
Hanlin (Harry) GaoChief Level Officer
Sell
Tax related
656$20.52$13,459.09962,035
27 May 2025
Jian (James) XiePresident/COO
Sell
Tax related
690$20.58$14,196.96373,814
27 May 2025
Jian (James) XiePresident/COO
Sell
Tax related
1,183$20.52$24,271.49372,631
26 May 2025
Ming HsiehChairman/CEO
Sell
Tax related
2,944$20.31$59,792.64810,679
26 May 2025
Paul KimCFO
Sell
Tax related
1,166$20.31$23,681.46343,702
23 May 2025
Ming HsiehChairman/CEO
Sell
Tax related
2,116$20.31$42,975.96813,623

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
5 March 2025
Paul KimCFO
Buy
Regular purchase transaction
100,000$15.96$1,596,470.00348,282
25 February 2025
Ming HsiehChairman/CEO
Sell
Tax related
19,997$16.29$325,751.13730,631
26 February 2025
Ming HsiehChairman/CEO
Sell
Tax related
11,773$16.24$191,193.52817,078
3 August 2024
Jian (James) XiePresident/COO
Sell
Tax related
6,719$25.06$168,378.14343,479
25 February 2025
Ming HsiehChairman/CEO
Sell
Tax related
9,543$16.29$155,455.47750,628

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.